How do I set a price alert for ADV.WA?

To set a ADV.WA price alert on Stock Alarm Pro, navigate to the ADV.WA quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Can I get phone call alerts for ADV.WA?

Yes. Stock Alarm Pro provides real-time automated phone call alerts for ADV.WA. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

What types of alerts can I set for ADV.WA?

Stock Alarm Pro supports over 125 trigger types for ADV.WA: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

How quickly will I be notified about ADV.WA price changes?

ADV.WA alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Is Stock Alarm Pro free to use for ADV.WA alerts?

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for ADV.WA and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

ADV.WA Company Intelligence - Business Model, Drivers & Risks

ADV.WA(ADV.WA)

$0.67—Stale · unknown old

WatchlistAsk SA Chart

ADV.WA(ADV.WA)

WSE • Last print unknown ago

$0.67—Stale · unknown old

WatchlistAsk SA Chart Studio

ADV.WA(ADV.WA)

ADV.WA

Adiuvo Investments S.A. focuses on developing innovative medical devices aimed at improving patient outcomes in the healthcare sector. The company operates primarily in Europe, leveraging advanced technology to create products that address unmet medical needs, particularly in surgical and rehabilitation markets.

HealthcareMedical - Deviceslow - The company has high fixed costs associated with R&D and manufacturing, leading to low operating leverage.

Business Overview

01Sales of surgical devices (estimated 70% of total revenue)

02Rehabilitation equipment sales (estimated 20% of total revenue)

03Consulting services for medical device implementation (estimated 10% of total revenue)

Adiuvo generates revenue through the sale of proprietary medical devices, which are priced at a premium due to their innovative features and clinical efficacy. The company benefits from strong pricing power owing to its unique product offerings and established relationships with healthcare providers.

What Moves the Stock

Approval of new medical devices by regulatory bodies in Europe

Partnerships with major healthcare providers for distribution

Clinical trial results demonstrating superior efficacy of products

Shifts in healthcare spending towards innovative medical technologies

Watch on Earnings

Revenue growth rateGross margin improvementNew product approval timelines

Risk Factors

Regulatory changes affecting medical device approvals

Technological disruption from emerging competitors

Increased competition from established medical device manufacturers

Potential market entry by new startups with innovative solutions

Negative gross margin indicates potential pricing pressures and cost management challenges

Low current ratio suggests liquidity risks in meeting short-term obligations

StructuralCompetitiveBalance Sheet

Macro Sensitivity

Economic Cycle

moderate - As a healthcare device manufacturer, Adiuvo's performance is somewhat insulated from economic downturns, but overall healthcare spending can be affected by GDP growth.

Interest Rates

Higher interest rates could increase financing costs for R&D and capital expenditures, potentially impacting growth initiatives and valuation multiples.

Credit

minimal - The company has a negative debt/equity ratio, indicating low reliance on external financing.

Live Conditions

Dow Jones FuturesS&P 500 FuturesRussell 2000 Futures